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enhance these protective effects in the hearts of diabetic rats. Chronic Resveratrol
treatment with Ipost neither reduced infarct size nor increased myocardial dysfunction
recovery in both diabetic and non-diabetic rats (infarct size: 59.5% and 59.2% in
diabetic ones and 45.0% and 43.7% in non-diabetic ones, P>0.05, respectively), and
this might be associated with an inhibition of Akt and eNOS phosphorylation.
Conclusions: The combination of acute Resveratrol treatment with Ipost shows a
stronger protective effect within the hearts of diabetic rats, but chronic Resveratrol
with Ipost fails to protect hearts against reperfusion injury in either diabetic or non-
diabetic rat hearts. These ﬁndings will be important for the design of future clinical
investigations.
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Objectives: Our studies demonstrate that deletion of the transient receptor potential
vanilloid type 1 (TRPV1) gene aggravates deoxycorticosterone acetate (DOCA) -salt
hypertension-induced renal injury, which is associated with increased intra-renal
monocyte/macrophage inﬁltration and inﬂammation. The results suggest that TRPV1
may act as a potential regulator of monocyte/macrophage inﬁltration to reduce renal
injury in DOCA-salt hypertension. Therefore, this study was designed to test the
hypothesis that deletion of TRPV1 exaggerates salt-sensitive hypertension-induced
renal injury via activation of chemokine receptor 2 (CCR2).
Methods:We induced salt-sensitive hypertension for 4 weeks by uninephrectomy and
DOCA-salt in wild type (WT) and TRPV1-null mutant (TRPV1-/-) mice with or
without the selective CCR2 antagonist, RS504393.
Results: DOCA-salt treatment increased systolic blood pressure (SBP) to the same
degree in both strains, but increased urinary excretion of albumin and 8-isoprostane
and decreased creatinine clearance with greater magnitude in TRPV1-/- mice
compared to WT mice (89.35.2 vs. 26.53.4 mg/24h; 4.240.45 vs. 1.520.21
ng/24h; 9819 vs. 16814 ml/24h, P<0.05). DOCA-salt treatment also caused
renal glomerulosclerosis, tubulointerstitial injury, collagen deposition, monocyte/
macrophage inﬁltration, proinﬂammatory cytokine and chemokine production,
and NF-kB activation in greater degree in TRPV1-/- mice compared to WT
mice (glomerulosclerosis index: 0.780.15 vs. 0.350.14; tubulointerstitial injury
score: 3.371.0 vs. 2.010.49; collagen content: 21.82.3 vs. 13.82.4 mg/mg dry
tissue; monocyte/macrophage inﬁltration: 744 vs. 425 cells/mm2; TNF-a:
1.030.22 vs. 0.760.21 pg/mg protein; MCP-1: 10.351.19 vs. 6.000.86 pg/mg
protein; p65-NF-kB protein: 545 vs. 363 ng/mg protein, P<0.05). Blockade of
the CCR2 with RS504393 (4 mg/kg) had no effect on SBP in DOCA-salt-treated
WT or TRPV1-/- mice compared to their respective controls. However, treatment
with RS504393 ameliorated renal dysfunction and morphological damage, and
prevented the increase in monocyte/macrophage inﬁltration, cytokine/chemokine
production, and NF-kB activity in both DOCA-salt hypertensive strains with a
greater effect in DOCA-salt-treated TRPV1-/- compared to DOCA-salt-treated
WT mice.
Conclusions: Our study showed that blockade of CCR2 with RS504393
attenuated DOCA-salt hypertension-induced renal injury in WT and TRPV1-/- mice
independently of their effects on blood pressure. The protective effect was greater in
TRPV1-/- mice compared to WT mice. The results suggest that deletion of TRPV1
aggravated salt-sensitive hypertension-induced renal damage possibly via activation of
the MCP-1/CCR2 signaling pathway. [This work was supported by a grant from the
National Natural Science Foundation of China (No. 81170243)].
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Objectives: It has been reported that the induction of heme oxygenase-1 (HO-1)
mediated by b1-adrenergic receptor inhibits high mobility group box 1 protein
(HMGB1) release and increases the survival rate in cecal ligation and puncture-
induced septic mice. The present study aimed to investigate whether dobutamine, a
selective b1-adrenergic receptor agonist, could inhibit HMGB1 release via
b1-adrenergic receptor-mediated HO-1 induction and attenuate myocardial ischemia/
reperfusion (I/R) injury in rats.
Methods: Anesthetized male rats were pretreated with dobutamine (5 or 10
microg.Kg-1. min-1, intravenous) before ischemia in the absence and/or presence of
LY294002 (0.3 mg/Kg), a phosphatidylinositol 3-kinase (PI3K) inhibitor; SB203580
(1 mg/Kg), a p38 mitogen-activated-protein kinase (P38 mitogen-activated-protein
kinase [p38 MAPK]) inhibitor, and zinc protoporphyrin IX ([ZnPPIX], 10 mg/Kg), a
HO-1 inhibitor, respectively, and then subjected to ischemia for 30 min followed by
reperfusion for 4 h. The myocardial I/R injury and oxidative stress were assessed.
Likewise, the expressions of HO-1 protein, nuclear factor kappa B (NF-kappaB) p65,
and HMGB1 were measured by Western blot analysis.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BResults: After 4 h reperfusion, compared with I/R group, the pretreatment of
dobutamine signiﬁcantly reduced the infarct size in a dose-dependent manner, and the
increase of LDH and CK levels were signiﬁcantly inhibited by dobutamine (both
P<0.05 versus I/R group). Meanwhile, dobutamine dose-dependently reduced
oxidative stress by inhibiting the increase of the MDA level and the decrease of the
SOD level (both P<0.05 versus I/R group). Otherwise, dobutamine produced a sta-
tistically signiﬁcant reduction in the production of TNF-a and IL-6 compared with the
I/R group (both P<0.05 versus I/R group). Furthermore, compared with I/R group,
dobutamine signiﬁcantly and dose-dependently mediated HO-1 induction and
NF-kappaB p65 and HMGB1 inhibition (all P<0.05 versus I/R group). However, all
the effects caused by dobutamine were signiﬁcantly reversed by the presence of
LY294002, SB203580, and ZnPPIX, respectively.
Conclusions: The present study demonstrated that dobutamine mediated the induction
of HO-1 by selectively stimulating b1-adrenergic receptor via PI3K and p38 MAPK,
which inhibited HMGB1 release and attenuated rat myocardial I/R injury in vivo.
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Objectives: Human Cytochrome P450 2J2 (CYP2J2) is the major arachidonic acid
epoxygenase, which can metabolizes arachidonic acid (AA) to biologically active
epoxyeicosatrienoic acids (EETs). The EETs are potent endogenous vasodilators and
inhibitors of vascular inﬂammation. Recently, much evidence from models and human
studies suggests that variability of CYP2J2 gene plays a mechanistic role in the
development of hypertension. The aim of the present study was to assess the asso-
ciation between the human CYP2J2 gene polymorphism and Essential Hypertension
(EH) in a Han and Uygur population in China.
Methods: We used two independent case-control studies: a Han population (302 EH
patients and 300 control subjects) and a Uygur population (567 EH patients and 215
control subjects). All EH patients and controls were genotyped for the same three
single nucleotide polymorphisms (SNPs) (rs890293, rs11572223 and rs2280275) of
CYP2J2 gene by a Real-time PCR instrument.
Results: In the Uygur population, the distribution of SNP3 (rs2280275) genotypes,
alleles and the dominant model (CC vs CT + TT) showed a signiﬁcant difference
between EH and control participants (for genotype: P¼0.007; for allele: P¼0.001; for
dominant model: P¼0.002). The signiﬁcant difference in dominant model was retained
after adjustment for covariates (OR: 3.500, 95% conﬁdence interval [CI]: 1.680-7.300,
P¼0.001). However, all the above differences were not shown in the Han population.
Conclusions: The CC genotype of rs2280275 in CYP2J2 gene could be a risk genetic
marker of EH and T allele may be a protective genetic marker of EH in Uygur
population in China.
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Objectives: Recent studies demonstrated that endothelial-derived microRNAs
(miRNAs) can be detected in clinical plasma/serum samples, and there are also evi-
dences indicated that inﬂammation disease states (e.g., atherosclerosis, cancer, etc.)
may affect the levels of circulating miRNAs, but so far there is no direct proof about
whether inﬂammation could induce endothelial cells to release miRNAs into circu-
lation.This study aimed to explore whether inﬂammation could induce endothelial
cells to release miRNAs into circulation and to investigate whether these released
miRNAs derived from endothelial cells were transported in microparticles.
Methods: Microparticles were isolated from human atherosclerotic plaques with an
active inﬂammatory phenotype and normal vascular tissue. Endarteretomy specimens
constituting the intima and inner media of carotid atherosclerotic regions were
obtained from the patients underwent carotid endarteretomy (CEA) (n¼9). Patients
undergoing coronary artery bypass surgery (CABG) procedure (n¼9) were included
as controls and the whole thickness vascular rings of normal vascular tissue (LIMA)
were obtained. Flow cytometry and real time PCR were used to detect the levels of
microparticles and microRNAs. To investigate whether these upregulated ECs-
enriched miRNAs levels in the MPs isolated from atherosclerotic plaques were caused
by inﬂammatory stimuli, human umbilical vein endothelial cells (HUVEC) were
treated with TNF-a (TNF-a group, n¼3) or DMEM (control group, n¼3) for 24
hours. and then HUVEC and the culture medium were respectively collected.
Results: By comparing microparticles isolated from human atherosclerotic plaques
with an active inﬂammatory phenotype (n¼9) and those from normal vascular tissues
(n¼9), we found levels of annexin V+ microparticles and annexin V+ CD144+
microparticles were signiﬁcantly increased in plaques (P <0.001) and angiogenesis-
associated miRNAs (106b, 25, 92a and 21) were also signiﬁcantly increased in
microparticles from plaques (P <0.05). After exposure to TNF-a at a concentration of
10 ng/ml (TNF-a group, n¼3) or DMEM (control group, n¼3) for 24 hours, counts of
microparticles and expressions of miRNAs-106b, 25, 92a and 21 in microparticlesasic and Translational Medicine C9
